St Jude Medical Company Profile (NYSE:STJ)

Notice: This company has been marked as potentially delisted and may not be actively trading.

About St Jude Medical (NYSE:STJ)

St Jude Medical logoSt. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Devices & Implants
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:STJ
  • CUSIP: 79084910
  • Web:
Average Prices:
  • 50 Day Moving Avg: $79.81
  • 200 Day Moving Avg: $79.88
  • 52 Week Range: $48.83 - $84.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 18.24
  • P/E Growth: 0.00
  • Annual Dividend: $1.24
  • Dividend Yield: 1.5%
  • Net Margins: 14.14%
  • Return on Equity: 19.40%
  • Return on Assets: 6.75%
  • Debt-to-Equity Ratio: 1.20%
  • Current Ratio: 1.93%
  • Quick Ratio: 1.31%
  • Average Volume: 2.63 million shs.
  • Beta: 1.23

Frequently Asked Questions for St Jude Medical (NYSE:STJ)

What is St Jude Medical's stock symbol?

St Jude Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "STJ."

How often does St Jude Medical pay dividends? What is the dividend yield for St Jude Medical?

St Jude Medical announced a quarterly dividend on Friday, December 9th. Investors of record on Friday, January 13th will be paid a dividend of $0.31 per share on Tuesday, January 31st. This represents a $1.24 annualized dividend and a dividend yield of 1.53%. The ex-dividend date is Wednesday, January 11th. View St Jude Medical's Dividend History.

How were St Jude Medical's earnings last quarter?

St Jude Medical Inc (NYSE:STJ) announced its earnings results on Wednesday, July, 20th. The company reported $1.06 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.06. The firm had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.55 billion. St Jude Medical had a net margin of 14.14% and a return on equity of 19.40%. The firm's revenue was up 10.8% compared to the same quarter last year. During the same period last year, the company earned $1.07 EPS. View St Jude Medical's Earnings History.

Where is St Jude Medical's stock going? Where will St Jude Medical's stock price be in 2017?

1 analysts have issued twelve-month price targets for St Jude Medical's shares. Their predictions range from $83.00 to $83.00. On average, they expect St Jude Medical's share price to reach $83.00 in the next year. View Analyst Ratings for St Jude Medical.

Who are some of St Jude Medical's key competitors?

What is St Jude Medical's stock price today?

One share of St Jude Medical stock can currently be purchased for approximately $80.82.

MarketBeat Community Rating for St Jude Medical (NYSE STJ)
Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  531 (Vote Outperform)
Underperform Votes:  540 (Vote Underperform)
Total Votes:  1,071
MarketBeat's community ratings are surveys of what our community members think about St Jude Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for St Jude Medical (NYSE:STJ) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $83.00 (2.70% upside)
Consensus Price Target History for St Jude Medical (NYSE:STJ)
Price Target History for St Jude Medical (NYSE:STJ)
Analysts' Ratings History for St Jude Medical (NYSE:STJ)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/22/2016Barclays PLCReiterated RatingEqual Weight$83.00N/AView Rating Details
10/11/2016Cowen and CompanyReiterated RatingBuy$85.00N/AView Rating Details
9/12/2016Jefferies Group LLCReiterated RatingHold$60.00N/AView Rating Details
8/28/2016ArgusReiterated RatingHoldN/AView Rating Details
8/28/2016Credit Suisse GroupReiterated RatingNeutral$81.00N/AView Rating Details
7/20/2016Canaccord GenuitySet Price TargetHold$85.00N/AView Rating Details
7/21/2016Leerink SwannReiterated RatingHold$85.00N/AView Rating Details
7/17/2016J P Morgan Chase & CoReiterated RatingHoldN/AView Rating Details
7/15/2016WedbushDowngradeOutperform -> Neutral$70.00 -> $84.00N/AView Rating Details
5/10/2016SunTrust Banks, Inc.DowngradeBuy -> Neutral$70.00 -> $80.00N/AView Rating Details
5/2/2016Morgan StanleyDowngradeOverweight -> Equal Weight$67.00 -> $81.00N/AView Rating Details
4/30/2016Wells Fargo & CompanyReiterated RatingHoldN/AView Rating Details
4/29/2016William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
4/29/2016Needham & Company LLCDowngradeBuy -> HoldN/AView Rating Details
4/28/2016Piper Jaffray CompaniesDowngradeOverweight -> NeutralN/AView Rating Details
4/18/2016BTIG ResearchDowngradeBuy -> NeutralN/AView Rating Details
4/15/2016Bank of America CorporationReiterated RatingBuy$66.00N/AView Rating Details
3/28/2016Oppenheimer Holdings, Inc.Boost Price TargetMarket Perform$57.00 -> $67.00N/AView Rating Details
3/28/2016BMO Capital MarketsBoost Price TargetOutperform$66.00 -> $73.00N/AView Rating Details
3/16/2016NomuraInitiated CoverageBuy$64.00N/AView Rating Details
1/25/2016Royal Bank Of CanadaLower Price TargetSector Perform$66.00 -> $57.00N/AView Rating Details
1/15/2016Deutsche Bank AGLower Price TargetHold$65.00 -> $64.00N/AView Rating Details
1/4/2016Sterne Agee CRTLower Price TargetBuy$81.00 -> $78.00N/AView Rating Details
10/22/2015Stifel NicolausDowngradeBuy -> HoldN/AView Rating Details
(Data available from 10/19/2015 forward)


Earnings History for St Jude Medical (NYSE:STJ)
Earnings by Quarter for St Jude Medical (NYSE:STJ)
Earnings History by Quarter for St Jude Medical (NYSE STJ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/19/2016Q316$1.01$0.99$1.50 billion$1.50 billionViewListenView Earnings Details
7/20/2016Q216$1.06$1.06$1.55 billion$1.56 billionViewListenView Earnings Details
4/20/2016Q116$0.88$0.90$1.43 billion$1.45 billionViewListenView Earnings Details
1/27/2016Q415$1.01$1.02$1.48 billion$1.45 billionViewListenView Earnings Details
10/21/2015Q315$0.97$0.97$1.35 billion$1.34 billionViewListenView Earnings Details
7/22/2015Q215$1.00$1.03$1.39 billion$1.41 billionViewListenView Earnings Details
4/22/2015Q115$0.91$0.93$1.32 billion$1.35 billionViewN/AView Earnings Details
1/28/2015Q414$1.03$1.03$1.44 billion$1.44 billionViewN/AView Earnings Details
10/15/2014Q314$0.96$0.97$1.39 billion$1.38 billionViewListenView Earnings Details
7/16/2014Q214$1.00$1.02$1.44 billion$1.45 billionViewN/AView Earnings Details
4/16/2014Q114$0.95$0.96$1.36 million$1.36 millionViewN/AView Earnings Details
1/22/2014Q413$0.97$0.99$1.38 billion$1.42 billionViewListenView Earnings Details
10/16/2013Q313$0.89$0.90$1.32 billion$1.34 billionViewListenView Earnings Details
7/17/2013Q2 2013$0.94$0.96$1.36 billion$1.40 billionViewListenView Earnings Details
4/17/2013Q1 2013$0.91$0.92$1.36 billion$1.34 billionViewListenView Earnings Details
1/23/2013Q4 2012$0.87$0.92$1.37 billion$1.37 billionViewListenView Earnings Details
10/17/2012$0.81$0.83ViewN/AView Earnings Details
7/18/2012$0.87$0.86ViewN/AView Earnings Details
4/18/2012$0.83$0.86ViewN/AView Earnings Details
1/25/2012$0.84$0.86ViewN/AView Earnings Details
10/19/2011$0.76$0.78ViewN/AView Earnings Details
7/20/2011$0.84$0.85ViewN/AView Earnings Details
4/20/2011$0.78$0.80ViewN/AView Earnings Details
1/26/2011$0.74$0.75ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for St Jude Medical (NYSE:STJ)
2017 EPS Consensus Estimate: $4.43
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$0.98$1.02$1.00
Q2 20175$1.12$1.17$1.14
Q3 20176$1.08$1.16$1.12
Q4 20175$1.14$1.26$1.18
Q1 20182$1.07$1.09$1.08
Q2 20182$1.22$1.30$1.26
Q3 20182$1.17$1.23$1.20
(Data provided by Zacks Investment Research)


Current Dividend Information for St Jude Medical (NYSE:STJ)
Most Recent Dividend:1/31/2017
Annual Dividend:$1.24
Dividend Yield:1.53%
Dividend Growth:7.60% (3 Year Average)
Payout Ratio:54.39% (Trailing 12 Months of Earnings)
30.85% (Based on This Year's Estimates)
27.99% (Based on Next Year's Estimates)
Track Record:6 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for St Jude Medical (NYSE:STJ)

Dividend History by Quarter for St Jude Medical (NYSE STJ)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for St Jude Medical (NYSE:STJ)
Insider Ownership Percentage: 4.80%
Institutional Ownership Percentage: 82.73%
Insider Trades by Quarter for St Jude Medical (NYSE:STJ)
Institutional Ownership by Quarter for St Jude Medical (NYSE:STJ)
Insider Trades by Quarter for St Jude Medical (NYSE:STJ)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/5/2016Jeff FechoVPSell10,408$51.71$538,197.68View SEC Filing  
12/21/2015Donald ZurbayCFOSell3,106$60.96$189,341.76View SEC Filing  
12/21/2015Jeff DallagerVPSell501$60.94$30,530.94View SEC Filing  
12/18/2015John C HeinmillerEVPSell8,009$61.16$489,830.44View SEC Filing  
10/28/2015Daniel J. StarksCEOSell120,000$62.36$7,483,200.00View SEC Filing  
4/28/2015Daniel J StarksCEOSell100,000$72.46$7,246,000.00View SEC Filing  
4/27/2015Mark W MurphyVPSell5,882$72.45$426,150.90View SEC Filing  
4/24/2015Jason ZellersVPSell3,566$74.13$264,347.58View SEC Filing  
4/24/2015Joel BeckerInsiderSell17,870$73.87$1,320,056.90View SEC Filing  
4/24/2015John C HeinmillerEVPSell160,000$73.69$11,790,400.00View SEC Filing  
4/24/2015Lisa AndradeCMOSell5,000$73.87$369,350.00View SEC Filing  
4/24/2015Stuart EssigDirectorSell7,750$73.85$572,337.50View SEC Filing  
4/22/2015I Paul BaeVPSell34,000$73.00$2,482,000.00View SEC Filing  
4/22/2015Lisa AndradeCMOSell5,000$70.55$352,750.00View SEC Filing  
2/10/2015Michael A RoccaDirectorSell3,875$65.57$254,083.75View SEC Filing  
2/6/2015Michael T RousseauCOOSell7,207$67.31$485,103.17View SEC Filing  
2/3/2015Denis M GestinInsiderSell148,500$67.13$9,968,805.00View SEC Filing  
2/3/2015Scott ThomeVPSell6,666$67.94$452,888.04View SEC Filing  
2/2/2015Mark W MurphyVPSell859$66.92$57,484.28View SEC Filing  
2/2/2015Richard R DevenutiDirectorSell7,750$66.43$514,832.50View SEC Filing  
12/18/2014John C HeinmillerEVPSell6,853$64.60$442,703.80View SEC Filing  
10/27/2014Jeff FechoVPSell500$60.55$30,275.00View SEC Filing  
10/23/2014Jason ZellersVPSell33,999$60.04$2,041,299.96View SEC Filing  
10/22/2014Daniel J StarksCEOSell100,000$60.04$6,004,000.00View SEC Filing  
7/30/2014Mark CarlsonVPSell1,198$66.40$79,547.20View SEC Filing  
7/29/2014Daniel J StarksCEOSell90,000$66.25$5,962,500.00View SEC Filing  
7/29/2014Mark W MurphyVPSell2,000$66.43$132,860.00View SEC Filing  
7/28/2014Denis M GestinInsiderSell99,000$66.76$6,609,240.00View SEC Filing  
7/28/2014Rachel EllingsonVPSell2,630$66.72$175,473.60View SEC Filing  
7/18/2014Scott ThomeVPSell5,997$67.06$402,158.82View SEC Filing  
2/6/2014Michael RoccaDirectorSell5,600$60.36$338,016.00View SEC Filing  
2/5/2014Scott ThomeVPSell7,500$59.57$446,775.00View SEC Filing  
2/4/2014Michael RousseauCOOSell4,644$59.76$277,525.44View SEC Filing  
1/27/2014Jeff FechoVPSell10,408$61.28$637,802.24View SEC Filing  
1/27/2014Joel BeckerInsiderSell14,164$61.58$872,219.12View SEC Filing  
1/24/2014Mark MurphyVPSell9,480$63.14$598,567.20View SEC Filing  
12/18/2013Joel BeckerInsiderSell37,916$59.54$2,257,518.64View SEC Filing  
12/18/2013John HeinmillerEVPSell4,144$59.49$246,526.56View SEC Filing  
12/16/2013Frank CallaghanInsiderSell73,826$59.28$4,376,405.28View SEC Filing  
12/9/2013Daniel StarksCEOSell108,000$59.41$6,416,280.00View SEC Filing  
11/5/2013Daniel StarksCEOSell108,000$57.33$6,191,640.00View SEC Filing  
10/31/2013Michael T RousseauInsiderSell50,000$57.81$2,890,500.00View SEC Filing  
10/29/2013Kathy ChesterVPSell9,375$58.12$544,875.00View SEC Filing  
10/29/2013Michael T RousseauInsiderSell50,000$57.76$2,888,000.00View SEC Filing  
10/28/2013Donald ZurbayCFOSell40,000$57.31$2,292,400.00View SEC Filing  
10/28/2013Mark W MurphyVPSell5,024$57.51$288,930.24View SEC Filing  
10/25/2013Jason ZellersVPSell14,917$57.15$852,506.55View SEC Filing  
10/24/2013Joel BeckerInsiderSell9,613$56.48$542,942.24View SEC Filing  
10/23/2013John C HeinmillerEVPSell150,000$56.48$8,472,000.00View SEC Filing  
10/23/2013Kathy ChesterVPSell20,000$56.50$1,130,000.00View SEC Filing  
10/22/2013Angela D CraigVPSell24,402$56.59$1,380,909.18View SEC Filing  
10/21/2013Frank J CallaghanInsiderSell133,096$56.26$7,487,980.96View SEC Filing  
10/21/2013Mark W MurphyVPSell3,930$56.26$221,101.80View SEC Filing  
10/18/2013Jason ZellersVPSell10,916$56.56$617,408.96View SEC Filing  
10/18/2013Michael T RousseauInsiderSell61,000$56.65$3,455,650.00View SEC Filing  
10/18/2013Wendy L YarnoDirectorSell22,150$56.50$1,251,475.00View SEC Filing  
10/4/2013Denis GestinInsiderSell137,000$55.25$7,569,250.00View SEC Filing  
10/4/2013Donald ZurbayCFOSell12,000$55.55$666,600.00View SEC Filing  
9/11/2013Mark MurphyVPSell4,200$53.50$224,700.00View SEC Filing  
8/9/2013Angela CraigVPSell13,600$54.00$734,400.00View SEC Filing  
8/9/2013Frank CallaghanInsiderSell11,000$54.00$594,000.00View SEC Filing  
7/29/2013Jason ZellersVPSell10,359$52.22$540,946.98View SEC Filing  
7/29/2013Stuart EssigDirectorSell5,600$52.19$292,264.00View SEC Filing  
7/25/2013Kathy ChesterVPSell16,250$52.00$845,000.00View SEC Filing  
7/22/2013Jason ZellersVPSell7,341$51.91$381,071.31View SEC Filing  
7/19/2013Donald ZurbayCFOSell50,000$51.28$2,564,000.00View SEC Filing  
7/19/2013Jeff FechoVPSell13,848$50.82$703,755.36View SEC Filing  
7/19/2013Joel BeckerInsiderSell11,700$50.50$590,850.00View SEC Filing  
5/2/2013Richard R DevenutiDirectorSell5,270$40.64$214,172.80View SEC Filing  
2/5/2013Denis M GestinInsiderSell90,000$41.32$3,718,800.00View SEC Filing  
2/5/2013Thomas R NorthenscoldVPSell22,000$41.40$910,800.00View SEC Filing  
10/25/2012John W BrownDirectorBuy25,000$38.65$966,250.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for St Jude Medical (NYSE:STJ)
Latest Headlines for St Jude Medical (NYSE:STJ)
DateHeadline logoAbbott beats Street on strong medical device, generics sales - October 19 at 9:22 AM logoRPRD Diagnostics Partners With St. Jude Children's Research Hospital To Offer Comprehensive Pharmacogenetics Testing - October 19 at 9:22 AM logoAbbott tops profit estimates on strong medical device sales - October 18 at 9:00 AM logoGlobal Pain Management Drugs & Devices Industry Forecasts (2017-2021) by Market Size (Volume and Value), Sales Price, &Gross Margin - October 14 at 8:15 AM logoGlobal Pain Management Drugs & Devices Industry Forecast to 2021 with Sales, Sales Price and Gross Margin Analysis - October 12 at 8:40 PM logoThe Melting Pot Announces 14th Year of Partnership with St. Jude Children's Research Hospital Thanks and Giving® Campaign - October 11 at 8:09 AM logoHead to Head Comparison: St Jude Medical (STJ) vs. Trivascular Technologies (TRIV) - October 7 at 12:18 AM logoMairs and Power Finds Value and Growth Close to Home - October 6 at 10:46 AM logoDiCello Levitt & Casey and Tousley Brain Stephens File Class Action Lawsuit Over Recalled Implantable Cardiac Defibrillators - September 20 at 9:32 AM logoHead to Head Review: RTI Surgical (RTIX) & St Jude Medical (STJ) - September 10 at 4:08 PM
News IconUPDATE 1-Abbott releases new round of cyber updates for St. Jude pacemakers - August 31 at 10:35 AM logoSt. Jude unveils powerful resource to advance treatment of pediatric solid tumors - August 31 at 10:34 AM logoAbbott issues second round of updates on St. Jude pacers - August 30 at 9:41 AM logoStryker Corporation (SYK) and St Jude Medical (STJ) Financial Review - August 28 at 2:24 PM logo2017 Health Care Heroes Lifetime Achievement: Dr. Larry Kun with St. Jude - August 18 at 7:32 AM logoBRIEF-IMF Bentham says Canadian unit proposes to fund class action against St. Jude Medical, Inc - August 14 at 6:01 AM logoSt Jude Medical (STJ) vs. Uroplasty (UPI) Head to Head Comparison - August 9 at 12:24 PM logoAnalyzing St Jude Medical (STJ) and Endologix (ELGX) - August 2 at 12:16 AM logoSt. Jude Children's Research Hospital®, ALSAC Announce Chairs of Boards of Directors and Governors - July 25 at 7:05 AM logoAbbott Labs sales increase as St. Jude devices rebound - July 22 at 9:12 AM logoSt. Jude-led researchers identify flu-risk genetic marker - July 18 at 8:34 AM logoToys"R"Us® Helps Raise Nearly $3 Million For St. Jude Children's Research Hospital® - July 13 at 9:57 AM logoHealthcare Uncertainty No Match For Abbott CFO - July 11 at 3:51 PM logoRenalGuard Solutions Appoints Jim Dillon, Former St. Jude Medical and Abiomed Executive, as Chief Executive Officer - July 10 at 8:49 AM logoSt. Jude Medical - June 7 at 10:25 AM logoSt. Jude-led study shows good news for childhood cancer survivors - June 5 at 10:13 PM logoCounty talks about pulling funding from Uptown, St. Jude efforts - May 3 at 6:13 PM
News IconUPDATE 1-Abbott sales, profit propped up by St. Jude acquisition - April 20 at 1:01 AM logoRecalled St. Jude devices were used in patients: FDA - April 17 at 8:51 AM logoSt. Jude Medical Played Down Defibrillator Failures for Years, F.D.A. Says - April 14 at 12:24 PM logoBenihana Supports St. Jude Children's Research Hospital® with 9th Annual Children's Day Initiative - April 3 at 7:47 PM logoCan Abbott Outperform Despite Alere? - TheStreet - - March 24 at 7:56 PM logoSt. Jude Medical, Inc. -- Moody's withdraws St. Jude Medical's note ratings - March 24 at 7:56 PM logoFormer St. Jude Medical V.P. admits swindling from company - March 9 at 7:58 PM logoFitch Rates Abbott's Notes Offering 'BBB'; Outlook Stable - February 28 at 7:39 PM logoBRIEF-FTC approves final order settling charges for Abbott's deal with St. Jude Medical - February 23 at 8:15 PM logoSt. Jude Children's Research Hospital® Thanks And Giving Raises $107 Million For The Research And Treatment Of Childhood Cancer - February 23 at 8:15 PM logoAbbott Laboratories -- Moody's assigns Baa3 to Abbott's proposed exchange notes - February 23 at 8:15 PM logoAbbott launches exchange offer for $3.1B in St. Jude debt - February 21 at 4:54 PM logoForm 425 ST JUDE MEDICAL, LLC Filed by: ABBOTT LABORATORIES - February 21 at 4:54 PM logoUbs Oconnor Llc Buys St Jude Medical, Gulfport Energy, Molson Coors Brewing Co, Sells Ingram ... - February 18 at 8:53 AM logoPublicly Traded Merger Arbitrage Funds' Top 10 Holdings Q4 2016 - Seeking Alpha - February 13 at 12:58 AM logoMedSec Provides A Timely Update On Abbott, St. Jude - Benzinga - February 8 at 6:22 AM logo[$$] Abbott Set for 12% EPS Growth - January 28 at 8:07 PM logoAbbott pauses on deals, to focus on St. Jude integration - January 26 at 6:06 AM



St Jude Medical (STJ) Chart for Thursday, October, 19, 2017

This page was last updated on 10/19/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.